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A B S T R A C T
Ethnopharmacological relevance: Capparis spinose (C. spinosa) belonging to Capparaeae, originates from dry areas
in the west or central Asia and Mediterranean basin. For thousands of years, C. spinosa has been reported to be
used as a therapeutic traditional medicine to relieve various ailments including rheumatism, pain and in-
flammatory diseases.
Aim of the study: There are several studies mentioning that systemic inflammation results in learning and memory
impairments through the activation of microglia. The objective of this study was to investigate the effect of C.
spinosa on both in vivo and in vitro models of neuroinflammation and cognitive impairment using lipopoly-
saccharide (LPS).
Materials and methods: In vivo: 40 male rats were used in the present study. Cognitive impairment was induced
using LPS (1 mg/kg/d; i.p.) for 4 weeks. Treatment with C. spinosa (100 and 300 mg/kg/d; p.o.) was performed
1 h before LPS administration. At the end of the experiment, rats were undergone for behavioral and biochemical
analysis. In vitro: Primary microglia isolated from mouse was used in the present study. The cells were pretreated
with C. spinosa extract (10–300 μg/ml) and then stimulated with LPS (1 μg/ml). The expression levels of in-
flammatory and anti-inflammatory cytokines were elucidated using Real-Time PCR and ELISA methods.
Results: The escape latency in the Morris water maze test in the LPS group was significantly greater than the
control group (p < 0.001), while, in extract-treated groups, it was less than the LPS group (p < 0.001).
Additionally, we found that the levels of IL-1β, TNF-α, and iNOS/Arg-1 ratio was also significantly lower in
extract-treated groups than the LPS group (p < 0.001). The results revealed that C. spinosa extract significantly
reduced the levels of TNF-α, iNOS, COX-2, IL-1β, IL-6, NO and PGE2, and the ratios of iNOS/Arg-1 and NO/urea,
following the LPS-induced inflammation in microglia (p < 0.001).
Conclusions: Our finding provides evidence that C. spinosa has a neuroprotective effect, and might be considered
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as an effective therapeutic agent for the treatment of neurodegenerative diseases that are accompanied by mi-
croglial activation, such as AD.
1. Introduction
Neuroinflammation and its chronicity in the brain are closely as-
sociated with the pathogenesis of a variety of neurodegenerative dis-
eases including Alzheimer's disease (AD), Parkinson's disease,
Huntington's disease, multiple sclerosis (MS), ischemic stroke (Askari
et al., 2018b; Askari and Shafiee-Nick, 2019a; Chen et al., 2016; Zipp
and Aktas, 2006). AD is considered a well-known progressive neuro-
degenerative disease, which is often connected with cognitive impair-
ment surprisingly in the elderly population. Recently, several studies
have established that inflammation plays a pivotal role in the patho-
genesis of AD. In this context, it has been indicated that systemic and
local inflammation can impress the mental functions, including
learning, memory and neuronal plasticity (Beheshti et al., 2019;
Harrison et al., 2014). Furthermore, it has been illustrated that in-
flammation acts an important role during learning and memory im-
pairments (Harrison et al., 2014). There is ample of evidence demon-
strating that brain inflammation is tightly associated with the spatial
learning impairment and memory dysfunction (Beheshti et al., 2019;
Harrison et al., 2014; Kim et al., 2012). Additionally, it has been re-
ported that the systemic inflammation is associated with cognitive
impairment (Kim et al., 2012).
Microglial cells are the major immune cells that reside in the brain
and play critical roles in neural homeostasis and neuroinflammation
due to lake of adaptive immune system (Askari et al., 2018a; Askari and
Shafiee-Nick, 2019a; Kaur et al., 2010; Kianmehr et al., 2017). The
microglial cells exhibit a similar pattern to other macrophages, de-
pending on the predominance of secreted factors, that two main phe-
notypes have been characterized for microglia, namely M1 (in-
flammatory cells; producing higher levels of tumor necrosis factor
(TNF)-α, interleukin (IL)-1β, prostaglandin E2 (PGE2), nitric oxide
(NO), and inducible nitric oxide synthase (iNOS)) and M2 (anti-in-
flammatory cells; producing higher levels of IL-10, arginase 1 (Arg1))
(Orihuela et al., 2016). Several experimental studies have indicated that
lipopolysaccharide (LPS) activates microglial cells through toll like re-
ceptor-4 (TLR-4) (He et al., 2018; Tai et al., 2018). Microglia activation
by LPS appears to exacerbate AD pathology associated with tau phos-
phorylation (Lee et al., 2010), amyloidogenesis and memory impair-
ment via TLR4 activation (He et al., 2018) as well as degenerative effect
on the dopaminergic system (Bansal and Singh, 2018; Tai et al., 2018).
In fact, several studies mentioned that both systemic and local exposure
to LPS result in inflammation, learning and memory impairments
through activation of microglia and increase in the levels of in-
flammatory cytokines and free radical production (Askari and Shafiee-
Nick, 2019a; Beheshti et al., 2019; Harrison et al., 2014; Kim et al.,
2012). Considering the important role of microglia-mediated neuro-
inflammation in the pathogenesis and progression of neurodegenerative
diseases, alterations in microglia M1/M2 polarization could be con-
sidered an emerging strategy for the prevention and treatment of sev-
eral neurodegenerative diseases, namely AD and MS (Hu et al., 2012;
Liu et al., 2015).
Capparis spinose (C. spinosa), which belongs to Capparaeae, origi-
nates from dry areas in west or central Asia and Mediterranean basin
(Trombetta et al., 2005). For thousands of years, C. spinosa has been
reported to be used as therapeutic traditional medicine to relieve var-
ious ailments (Aliyazicioglu et al., 2013; Romeo et al., 2006) such as
rheumatism, rheumatoid arthritis and gout (Rahnavard and Razavi,
2016; Zhang and Ma, 2018). In the traditional medicine, C. spinosa has
been applied for treatment different types of pain since ancient times
(Fu et al., 2008). Different parts of the medicinal plant (aerial parts,
roots, and seeds) have been known to exhibit multiple biological ac-
tivities including anti-inflammatory, anti-allergic and anti-histaminic,
antiviral and immune-modulatory, antioxidant, antimicrobial proper-
ties (Kulisic-Bilusic et al., 2012; Tlili et al., 2011; Trombetta et al.,
2005). Moutia et al., 2016 recently showed that aerial part of C. spinosa
up-regulates the gene expression of an anti-inflammatory cytokine in-
terleukin (IL)-4, whereas down-regulates the levels of pro-inflammatory
cytokine IL-17 gene expression, in human on peripheral blood mono-
nuclear cells (PBMC) (Zhang and Ma, 2018). Basis on this, in the pre-
sent study, we aimed to evaluation of the anti-inflammatory and im-
munomodulatory effects of C. spinosa both in vivo and in vitro
(microglia) against LPS-induced neuroinflammation and memory dys-
function.
2. Material and methods
2.1. Chemicals and reagents
Dulbecco's Modified Eagle's Media (DMEM)/F12 culture media,
penicillin/streptomycin (pen/strep), amphotericin-B, Fetal bovine
serum (FBS), Dimethyl sulfoxide (DMSO), Ficoll, DNAse I, Dispase II,
Lipopolysaccharides (LPS), and other cell culture chemicals were pro-
vided from Sigma-Aldrich Chemical Co. (St. Louis, MO, USA). Red
blood cells (RBC) lysis buffer was obtained from Biolegend company
(San Diego, CA, USA). (3-(4,5-dimethylthiazol-2-yl)- 2,5-diphenyl tet-
razolium bromide (MTT) was from Roche Diagnostic (Mannheim,
Germany). IL-6, IL-10, IL-β, TNF-α ELISA kits were purchased from and
eBioscience (San Diego, CA, USA). All other materials were of analytical
and standard grade and purchased from Sigma-Aldrich Chemical Co.
(St. Louis, MO, USA). Urea kit was obtained from Abcam.
2.2. Plant collection and extraction
The aerial parts of C. spinosawere collected from plants cultivated in
the Kalat region, Khorasan Razavi province, Iran. The identification of
the specimen was established by a botanist (Mrs. Sozani) at School of
Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran, and
deposited in the herbarium of Ferdowsi University of Mashhad (her-
barium No. 13063).
C. spinosa aerial parts were air dried in the shadow and ground to
fine powder. The extraction was done by the maceration method. In
brief, the dried powdered aerial parts (100 g) were soaked in 70% v/v
of the hydro-ethanolic solution for 72 h along with light shaking.
Afterward, the mixture was filtered using Whatman No. 1 filter paper.
After centrifuging at 3000 rpm (round per minute) for 5 min, the su-
pernatant was concentrated by a rotary evaporator (37 °C) and then
were undergone freeze dry process to eliminate ethanol/water and
prepare a fine powder. The yield of the extract was 18.9% w/w of the
dry powder, and was stored at -80 °C until used.
2.3. Liquid chromatography–mass spectrometry (LC-MS) apparatus and
standardization procedures
The LC-MS analysis was performed in an AB SCIEX QTRAP
(Shimadzu) liquid chromatography equipped with triple quadrupole
Mass Spectrometer. Liquid chromatography separation was performed
on a Supelco C18 (15 mm× 2.1 mm× 3 μm) column. The analysis was
done at a flow-rate of 0.2 ml/min with a mixture of methanol and water
(90:10) and the mass spectra were acquired in a range of 150 to 1700
within the 60 min scan time. The positive electrospray ionization (ESI)
1 These authors share the first co-authorship equally.
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mode was applied for the Mass Spectrometer. Mass feature extraction of
the acquired LC-MS data and maximum detection of peaks was done
using MZmine analysis software package, version 2.3.
2.4. In vivo study
2.4.1. Animals and husbandry
Forty male Wistar rats (weighted 230 ± 15 g) were purchased from
the animal laboratory of Mashhad University of Medical Sciences. Then,
all rats were randomly divided into four groups of ten in separately
ventilated cages (22 ± 2 °C, humidity of 54 ± 2% and 12 h light/dark
cycle). All animals had free access to food and taped drinking water.
The experimental procedures were approved by the Ethical Committee of
Animal Research (961339; IR.MUMS.MEDICAL.REC.1397.041).
2.4.2. Study design and experimental groups
LPS was freshly prepared in sterile saline before injection. Grouping
was performed as follows (Table 1); Group 1, Control: rats received
saline instead of either LPS or the extract; Group 2, LPS: rats received
daily and intraperitoneally (i.p.) injection of LPS (1 mg/kg) for 4 weeks
and also 120 min before behavioral tests. These animals received 5 ml/
kg saline instead of the extract.
Groups 3 and 4, the extract treated: rats received 100 mg/kg/d and
300 mg/kg/d of the extract by oral gavage, 1 h before LPS injection
(1 mg/kg/d; i.p.); the rats were treated for 4 weeks. Selection of doses
of the extract ((Goel et al., 2016; Kalantari et al., 2017; Turgut et al.,
2015)) and LPS ((Beheshti et al., 2019)) were according to the pre-
viously published studies.
2.4.3. Morris water maze (MWM) test
The MWM test was carried out using the black circle pool (60 cm
depth, and 150 cm diameter) half full of water (24 ± 1 °C), describing
elsewhere (Beheshti et al., 2019). Briefly, the procedure included five
consecutive days of training with another day for a probe test. In this
experiment, the evaluations were performed four trials for each rat per
day from different release positions to find the location of a plexiglas
platform (located two cm below the water level). Noteworthy, if the rat
was not able to find the platform during 60 s of the acquisition phase, it
was climbed on the platform for 15 s. During the training days, the
distances traveled and the time spent to find the platform were assessed
and compared as behaviors between the groups. Probe test was done on
the 6th day without the platform. The rat was recorded for 60 s to
search the maze, and the time spent in the platform position was re-
corded. A video-tracking system was used to record the latency of
finding the platform.
2.4.4. Measurement of the levels of TNF-α, IL-1β, and IL-10 by ELISA
The levels of TNF-α, IL-1β, and IL-10 were measured in the whole
brain tissue using ELISA kits according to the manufacturer's protocol
(Askari et al., 2018b, 2018c; Askari and Shafiee-Nick, 2019b; Lee and
Tansey, 2013; Rahimi et al., 2018).
2.4.5. Quantitative real-time PCR (qPCR)
Whole brain tissue was homogenized and transferred into the TRIzol
reagent for RNA extraction. RNA was extracted in accordance with the
manufacturer's instruction. Primer sequences used for Arg-1 (Forward:
5′-GGCAGTGCCGTTGACCTTGT-3′, Reverse: 5-AGCAGCGTTGGCCTGG
TTCT-3’ (Amrouni et al., 2011)), iNOS (Forward: 5′-CACCACCCTCCT
TGTTCAAC-3′, Reverse: 5′-CAATCCACAACTCGCTCCAA-3′ (Nergiz
et al., 2012)) and Glyceraldehyde-3-Phosphate Dehydrogenase
(GAPDH, Forward: 5′-GGAGAAAGCTGCTAA-3′, Reverse: 5′-ACGACCT
GGTCCTCGGTGTA-3’ (Sobajima et al., 2005)) were according to the
previous studies designed with mRNA sequences. The real-time PCR
reactions were performed using the SYBR® Green Master Mix and re-
ference genes quantification by a Rotor-Gene Q Real-Time PCR machine
(Corbett Research, Australia) according to our previous studies (Askari
et al., 2016, 2018c; Askari and Shafiee-Nick, 2019b; Lee and Tansey,
2013; Rahimi et al., 2018). Statistical analysis of gene expression levels
was performed by the 2-△△Ct method and expressed as fold-changes of
the control group.
2.5. In vitro study
2.5.1. Microglia isolation, cell culture and treatment
Primary microglial cells were isolated from 8-weeks-old (28 ± 5 g)
male C57BL/6 mice as described in our previous studies (Askari et al.,
2018c; Askari and Shafiee-Nick, 2019b; Lee and Tansey, 2013; Rahimi
et al., 2018). The microglial cells isolated from adult mice brain were
cultured in enriched-DMEM (1% v/v of Pen/Strep (100 x), 10% v/v of
heat-inactivated FBS, 0.5 μg/mL amphotericin B, and 2 mM L-gluta-
mine) in a humidified incubator at 37 °C, where CO2 accounted for 5%
v/v. The cultured cells were treated with 1 μg/ml LPS, the optimal
concentration to stimulate the cells, in the presence or absence of
30–300 μg/mL C. spinosa extract or dexamethasone (0.5 μM) as positive
control (Feng et al., 2017). Treatment groups were presented in Table 1.
C. spinosa extract was dissolved in DMSO to prepare a concentration of
50 mg/mL and serially diluted with the complete medium. For all ex-
periments, the level of DMSO was lower than 0.1% v/v, and the dif-
ferent concentrations of the extract freshly prepared.
2.5.2. Cell proliferation assay
Microglial cells were seeded at a density of (1 × 105 cells/ml) to 96-
well plates. Afterward, the cells were treated with C. spinosa extract
(1–300 μg/ml), dexamethasone (0.5 μM) as positive control (Feng et al.,
2017), and C. spinosa extract (30–300 μg/ml) or dexamethasone
(0.5 μM) as positive control + LPS (1 μg/ml), and incubated for 48 h at
37 °C in 5% CO2 incubator. MTT solution (0.5 mg/ml) subsequently was
added to each well which incubated for next 3 h. Then, the culture
media were removed and replaced by DMSO (100 μl/well) to dissolved
crystals. The absorbance was read at 570 nm in referencing 620 nm
with a StatFAX 2100 microplate reader (Awareness Inc, USA) (Askari
et al., 2018c; Askari and Shafiee-Nick, 2019b; Lee and Tansey, 2013;
Rahimi et al., 2018).
2.5.3. Measurement of the levels of TNF-α, IL-1β, IL-6, and PGE2
The levels of inflammatory mediators were assessed in the culture
medium collected from microglial cells after treatment with LPS (1 μg/
ml) or LPS with the extract or dexamethasone as positive control by
ELISA kits according their instructions (Askari et al., 2018b, 2018c;
Askari and Shafiee-Nick, 2019b; Lee and Tansey, 2013; Rahimi et al.,
2018).
Table 1
Protocol of treatment groups.
In vivo study
Groups Vehicle LPS (1 mg/kg/d) C. spinosa extract (mg/kg/d)
1 √ – -
2 √ √ -
3 √ √ 100
4 √ √ 300
In vitro study
Groups Vehicle LPS (1 μg/ml) C. spinosa extract (μg/ml)
1 √ – –
2 √ – 300
3 √ √ –
4–6 √ √ 30, 100 and 300
7 √ √ 0.5 μM Dexamethasone
8 √ – 0.5 μM Dexamethasone
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2.5.4. Quantitative real-time PCR (qPCR)
Microglial cells were incubated with LPS (1 μg/mL) in the presence
or absence of 10, 30, 300 μg/mL of C. spinosa extract or dexamethasone
(0.5 μM) as positive control for 6 h. GAPDH as the reference gene, was
used to evaluate the relative expression of iNOS, TNF-α, and IL-1β.
Grouping was done according to the experimental design, while the
duration of exposer to evaluate the mRNA for all groups was 6 h. Primer
sequences used for Arg-1, iNOS, TNF-α, Il-1β, IL-6 has been depicted in
Table 2. The primers sequences were obtained according to the pre-
vious studies designed with mRNA sequences (Askari et al., 2016,
2018c; Askari and Shafiee-Nick, 2019b; Lee and Tansey, 2013; Rahimi
et al., 2018). The real-time PCR reactions were performed using the
SYBR® Green Master Mix and reference genes quantification by a Rotor-
Gene Q Real-Time PCR machine (Corbett Research, Australia) ac-
cording to our previous studies (Askari et al., 2016, 2018c; Askari and
Shafiee-Nick, 2019b; Lee and Tansey, 2013; Rahimi et al., 2018). Sta-
tistical analysis of gene expression levels was performed by the 2-△△Ct
method and expressed as fold-changes of the control group.
2.5.5. Nitric oxide and urea assay
The content of the concentration of produced nitrite metabolites
was measured using the Griess method to reflect the NO concentration
(Ramirez et al., 1996). After treatment of microglia with LPS (1 μg/mL)
in the presence or absence of 30, 100, 300 μg/mL the extract, the
culture media was collected for NO assay. The culture media (50 μL)
was centrifuged at 400×g for 10 min to remove cells and then in-
cubated with equal volumes of Sulfanilamide and N-(1-Naphthyl)-
ethylenediamine in 2N hydrochloric acid at controlled room tempera-
ture for 10 min. The concentration of nitrite was determined using
sodium nitrite standard curve (Askari et al., 2016). Meanwhile, using
sodium nitrate as a standard, absorbance values were measured at
540 nm in a spectrophotometer. Urea concentration was also assessed
using a colorimetric assay kit from Abcam according to the manufac-
turer's instruction. In brief, 50 μL of supernatant was used for evalua-
tion of the amount of urea, after that, assay buffer and reaction mix
were added, and analyzed in 570 nm with ELISA reader.
2.6. Statistical analysis
The results were presented as means ± SEM (standard deviation).
All data were analyzed using one-way analysis of variance (ANOVA)
with the Tukey post hoc test (for multiple comparisons) to compare
means among groups, when passed the normality test
Kolmogorov–Simonov. However, data from behavioral test (MWM)
were analyzed using repeated measures two-way ANOVA with the
Tukey post hoc test. A p-value ≤ 0.05, 0.01 and 0.001 was considered
statistically significance.
3. Results
3.1. LC-MS analysis of C. spinosa extract
The presence of glycosylated flavonols has been reported in dif-
ferent C. spinosa extracts. In total, 25 compounds were identified in the
hydro-ethanol extract of the aerial parts of C. spinosa. Data concerning
the compounds identification are shown in Table 2. The MS spectral
data were compared with the reported compounds in some previous
literature. Flavonoids were the major identified components and among
them, quercetin and kaempferol derivatives were predominate in C.
spinosa, especially kaempferol, 3-O-rutinoside. These results were in
agreement with the literature that reported rutin and kaempferol 3-O-
rutinoside as major flavonoids from C. spinosa (Fig. 1A–D). Therefore,
the aerial parts of C. spinosa are good sources of quercetin and
kaempferol derivatives for production purposes.
3.2. In vivo studies
3.2.1. The effects of C. spinosa extract and LPS on MWM test
Our result showed that administration of LPS (1 mg/kg/day; i.p.)
alone provides higher escape latency time and traveled distance to
reach the platform in comparison to the control group in the training
phase (days one to five, p < 0.001 for both cases, Fig. 2A and C).
Furthermore, we observed that there are significant differences in the
escape latency time and also traveled distance to reach the platform
Table 2
Peak assignment of metabolites in hydro-ethanol extract of C. spinosa using LC–MS in the positive mode.
Compounds Rt (min) M+ (Calc.) [M+H]+ m/z References
Capparine A 10.1 280.03 281.34 Zhou et al. (2010)
Flazine 4.8 30.08 309.30 Zhou et al. (2010)
Guanosine 4.4 283.09 284.04 Zhou et al. (2010)
Cappariloside A 2.2 334.33 335.34 Yang et al. (2010)
4-hydroxy-1H-indole-3-carboxaldehyde 4.2 161.05 162.96 Zhou et al. (2010)
Kaempferol 4.9 286.05 287.70 Zhou et al. (2010)
Thevetiaflavone 5.1 284.07 285.00 Zhou et al. (2010)
Glucocapparin 2.4 333.02 334.32 Matthäus and Özcan (2002)
Ginkgetin 3.6 566.12 567.18 Zhou et al. (2011)
Sakuranetin 5.2 286.08 286.92 Zhou et al. (2011)
Quercetin-7-rutinoside 3.4 610.15 611.58 Sharaf et al. (1997)
Rutin 9.2 610.15 611.7 Mollica et al. (2017)
Chrysoeriol 4.2 300.06 301.8 Zhou et al. (2010)
Kaempferol hexoside dirhamnoside 2.9 739.22 740.20 Rodrigo et al. (1992)
Kaempferol 3-O-rutinoside 3.6 594.16 595.2 Inocencio et al. (2000)
Kaempferol glucuronide 3.5 462.08 463.44 Bakr and El Bishbishy (2016)
Kaempferol rutinoside hexoside 4 756.21 757.14 Inocencio et al. (2000)
Kaempferol dihexoside dirhamnoside 3.6 90.24 903.54 Bakr and El Bishbishy (2016)
Kaempferol-3-glucoside 3.4 448.10 449.76 Rodrigo et al. (1992)
Quercetin-3-O-hexose-O-pentoside 3.7 596.13 597.36 Bakr and El Bishbishy (2016)
Quercetin dihexoside 3.8 626.15 627.24 Bakr and El Bishbishy (2016)
Quercetin acetyl hexoside 3.7 506.11 507.480 Bakr and El Bishbishy (2016)
Quercetin-3-O-glucoside 3.6 464.10 464.58 Sharaf et al. (2000)
p-Coumaroyl quinic acid 8.3 338.10 339.42 Bakr and El Bishbishy (2016)
Eriodictyol-7-O-rutinoside 3.5 596.17 597.18 Aliyazicioglu et al. (2013)
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among 5-days of training in all treated groups (p < 0.001 for all cases,
Fig. 2A and C). However, the levels of escape latency time and traveled
distance to reach the platform were significantly lower in the extract
(100 and 300 mg/kg) treatment groups compared to the LPS group
(p < 0.001 for all cases, Fig. 2A and C). On probe date (6th days), the
LPS-treated group significantly spend less time in the target quadrant
and cannot recall the platform location in comparison to the control
group (p < 0.001, Fig. 2B). In contrast, in the probe trial day, the level
of spent time in the target quadrant was significantly higher in the
groups receiving 100 and 300 mg/kg of the extract in comparison to the
LPS-treated group (p < 0.01 and p < 0.001, respectively, Fig. 2B).
3.2.2. The effects of C. spinosa extract and LPS on brain IL-1β, TNF-a and
IL-10 levels
In group received LPS (1 mg/kg/d; i.p), the levels of inflammatory
cytokines (IL-1β and TNF-α) were dramatically increased in the whole
brain, in comparison to the control group (p < 0.001 for both cases,
Fig. 3A and B). In contrast, the level of IL-10, anti-inflammatory cyto-
kine, was significantly decreased in the whole brain of LPS-treated
groups compared to the control group (p < 0.001, Fig. 3C). Interest-
ingly, our findings showed that the groups receiving the dose of 100
and 300 mg/kg of C. spinosa extract have lower levels of inflammatory
cytokines (IL-1β and TNF-α) in the whole brain homogenate in
Fig. 1. Chromatogram and corresponding mass adducts. A) Total ion chromatogram of C. spinosa L. extract. B) Kaempferol 3-O-rutinoside chromatogram and
corresponding mass adducts. C) Quercetin-3-O-glucoside chromatogram and corresponding mass adducts. D) Kaempferol hexoside dirhamnoside chromatogram and
corresponding mass adducts.
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comparison to the LPS-treated group (p < 0.001–0.01 for all cases,
Fig. 3A and B). Moreover, the results indicated that the level of anti-
inflammatory cytokine IL-10 was significantly enhanced in the whole
brain homogenate of the extract-treated (100 and 300 mg/kg; p.o.)
groups, comparing to the LPS-treated group (p < 0.001 for both cases,
Fig. 3C).
3.2.3. The effects of C. spinosa extract and LPS on brain iNOS and Arg-1
levels, and iNOS/Arg-1 (M1/M2) ratio
The mRNA expression levels of microglial marker iNOS (M1 type)
and Arg1 (M2 type) were detected using real time-PCR in the whole
brain homogenates. In this experiment, treatment with LPS led to a
significant reduction in Arg1 gene expression level in comparison to the
control group (p < 0.01, Fig. 4A). In contrast, the gene expression
level of iNOS was markedly up-regulated in comparison to the control
group (p < 0.001, Fig. 4B). Accordingly, treatment with LPS sig-
nificantly propagated the ratio of iNOS/Arg1 (M1/M2) in comparison
to the control group (p < 0.001, Fig. 4C). On the other hand, in
comparison to the LPS group, C. spinosa extract (100 and 300 mg/kg)
notably increased the level of Arg1 gene expression, while decreased
the level of iNOS gene expression (p < 0.001 for all cases, Fig. 4A and
B). Moreover, the extract (100 and 300 mg/kg) significantly diminished
the ratio of iNOS/Arg1 (M1/M2), compared to the LPS-treated group
(p < 0.001 for both cases, Fig. 4C).
Fig. 1. (continued)
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3.3. In vitro studies
3.3.1. The effects of C. spinosa extract and LPS on the proliferation of
microglial cells
C. spinosa (1–300 μg/mL) and dexamethasone (0.5 μM) exerted no
significant effects on proliferation level of microglial cells (Fig. 5A). Our
records indicated that LPS (1 μg/mL) significantly reduced the level of
cell proliferation compared to the respected control group (p < 0.001,
Fig. 5B). The extract (100 and 300 μg/mL) and also dexamethasone
(0.5 μM) significantly enhanced the cell proliferation of LPS-treated
microglial cells compared to the LPS group (p < 0.05–0.001 for both
cases, Fig. 5B).
3.3.2. The effects of C. spinosa extract and LPS on the pro-inflammatory
cytokine level
As presented in Fig. 6, treatment of the cells with LPS significantly
increased the mRNA expression levels of pro-inflammatory cytokines
(TNF-α, IL-6, and IL-1β) when compared to the non-stimulated cells
(p < 0.001, Fig. 6A-C). In the presence of LPS-stimulation, the mRNA
expression levels of TNF-α (p < 0.01–0.001 for all cases), IL-1β
(p < 0.01–0.001 for all cases), and IL-6 (p < 0.001 for all cases) were
markedly decreased following the treatment with C. spinosa extract
(30–300 μg/ml, in a concentration dependent manner) or dex-
amethasone (0.5 μM) (Fig. 6A–C). In our study, we also assessed the
protein levels of pro-inflammatory cytokines (TNF-α, IL-6, and IL-1β)
using ELISA method. In the presence of LPS, the protein levels of these
pro-inflammatory cytokines were notably elevated in comparison to the
non-stimulated cells (p < 0.001 for all cases, Fig. 7A). In contrast,
treatment with the extract (30–300 μg/ml, in a concentration-depen-
dent manner) or dexamethasone (0.5 μM) resulted in a significant de-
crease in the levels of TNF-α (p < 0.01–0.001 for all cases), IL-6
(p < 0.001 for all cases), and IL-1β (p < 0.01–0.001 for all cases)
when compared to the LPS-stimulated cells (Fig. 7A–C).
We also revealed that in the extract treated groups the levels of TNF-
α (30 and 100 μg/ml of the extract; 0.001 for all cases; Figs. 6A and
7A), IL-6 (30 and 100 μg/ml of the extract; 0.001 for all cases; Figs. 6B,
and Fig. 7B) and IL-1β (30, 100 and 300 μg/ml of the extract;
p < 0.01–0.001 for all cases; Figs. 6C, and Fig. 7C) cytokines at both
gene expression and protein levels were remarkably lower than dex-
amethasone (0.5 μM; Figs. 6 and 7) treated group.
Fig. 2. The effects of C. spinosa extract and LPS on the levels of time latency (A), time spent in target quadrant (B) and distances to reach the platform (C), in MWM
test. The data were presented as mean ± SEM; n = 10 per group. a p < 0.05 and aaa p < 0.001, compared dose of 100 mg/kg to LPS group; bb p < 0.01 and bbb
p < 0.001, compared dose of 300 mg/kg to LPS group; c p < 0.05 and ccc p < 0.001, compared control group to LPS group. ##p < 0.01 and ###p < 0.001,
compared with the LPS group; ***p < 0.001, compared with control group. The presented data in Fig. 2A) and C) were analyzed using repeated measure two-
ANOVA with the Tukey post hoc test. However, The presented data in Fig. 2B) were analyzed by one-way ANOVA with the Tukey post hoc test. LPS, lipopoly-
saccharide; SEM, standard error mean.
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Fig. 3. Effects of C. spinosa extract on pro-inflammatory factors of A) TNF-α, B)
IL-6, and C) IL-1β in the whole brain of rats. Concentrations of TNF-α, IL-6, IL-
1β were determined using ELISA. Data represented as mean ± SEM; n = 10
per group. ##p < 0.01 and ###p < 0.001, compared with LPS group;
***p < 0.001, compared with control group. The presented data were ana-
lyzed by one-way ANOVA with the Tukey post hoc test. LPS, lipopolysaccharide;
SEM, standard error mean; TNF-α, Tumor necrosis factor-α, IL-1β, Interleukin
1-β; IL-6, Interleukin-6.
Fig. 4. Effects of C. spinosa extract on the mRNA expression levels of iNOS (A)
and Arg1 (B), and iNOS/Arg1 ratio (C) in the whole brain of rats. The ex-
pression levels of iNOS and Arg1 were evaluated by real time-PCR. Data re-
presented as mean ± SEM; n = 10 per group. ###p < 0.001, compared with
LPS group; ***p < 0.001, compared with the control group. The presented
data were analyzed by one-way ANOVA with the Tukey post hoc test. LPS, li-
popolysaccharide; SEM, standard error mean; Arg1, arginase-1; iNOS, inducible
nitric oxide synthase.
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3.3.3. The effects of C. spinosa extract and LPS on the level of PGE2 and
COX-2
LPS stimulation caused a significant increase in the production level
of PGE2 in comparison to the control group (p < 0.001, Fig. 8A). In
contrast, a significant inhibition of PGE2 production was found with
either all evaluated concentrations of the extract (30–300 μg/ml) or
dexamethasone (0.5 μM) compared to the LPS group (p < 0.001 for all
cases, Fig. 8A). In order to determine whether the inhibitory effects of
C. spinosa extract on PGE2 production were possibly due to the decrease
in the mRNA expression level of COX-2, an enzyme responsible for
PGE2 production, the mRNA expression level of COX-2 was also ex-
amined by real time-PCR analysis. In response to LPS, the gene ex-
pression of COX-2 was markedly up-regulated comparing to the non-
stimulated cells (p < 0.001, Fig. 8B). However, in comparison to the
LPS-treated group, treatment with C. spinosa extract (30–300 μg/ml,
concentration-dependently) or dexamethasone (0.5 μM) could sig-
nificantly attenuate the gene expression level of COX-2
(p < 0.001–0.01 for all cases, Fig. 8B). Moreover, the impact of dex-
amethasone (0.5 μM) on the reduction of PGE2 level was significantly
greater than all assessed concentrations (30–300 μg/ml) of C. spinosa
extract (p < 0.001 to 0.01 for all cases, Fig. 8A), however, COX-2
expression level was observed significantly higher only at 30 μg/ml
concentration of the extract in comparison to the dexamethasone
(0.5 μM) (p < 0.001, Fig. 8B).
3.3.4. The effects of C. spinosa extract and LPS on the levels of iNOS, Arg-1
and iNOS/Arg-1(M1/M2) ratio
To further investigate the effect of C. spinosa on microglia activation
and function, the mRNA expression of microglial marker iNOS (M1
Fig. 5. The effects of C. spinose extract on proliferation level of microglia cells.
(A) Cells were treated with the extract (1–300 μg/mL) for 48 h. (B) Cells were
treated with the extract for 24 h before exposure to LPS (1 μg/mL). Cell pro-
liferation was measured using MTT assay. Data represented as mean ± SEM;
n = 6 per group. ###p < 0.001, compared with LPS group; ***p < 0.001,
compared with the control group. The presented data were analyzed by one-
way ANOVA with the Tukey post hoc test; LPS, lipopolysaccharide; SEM, stan-
dard error mean; Dexa, dexamethasone (0.5 μM).
Fig. 6. Effects of C. spinose extract on the mRNA expression levels of pro-in-
flammatory factors of A) TNF-α, B) IL-6, and C) IL-1β in LPS-stimulated mi-
croglial cells. The levels of TNF-α, IL-6, and IL-1β were assessed using real-time
PCR. Data represented as mean ± SEM; n = 6 per group. ###p < 0.001,
compared with LPS group; ***p < 0.001, compared with the control group; +
++ p < 0.001, compared with Dexa group. The presented data were analyzed
by one-way ANOVA with the Tukey post hoc test. LPS, lipopolysaccharide; SEM,
standard error mean; TNF-α, Tumor necrosis factor-α, IL-1β, Interleukin 1-β; IL-
6, Interleukin-6; Dexa, dexamethasone (0.5 μM).
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cells) and Arg1 (M2 cells) were detected using the real time-PCR. In the
presence of LPS-stimulation, the gene expression level of iNOS was
markedly up-regulated in comparison to the non-stimulated cells
(p < 0.001, Fig. 9A). In this experiment, LPS also led to a reduction in
Arg1 gene expression level, but this was not statistically significant in
comparison to the control group (Fig. 9B). Collectively, our analysis
showed that LPS-stimulation significantly enhances iNOS/Arg1 (M1/
M2) ratio compared to the control cells (p < 0.001, Fig. 9C).
In comparison to the LPS group, treatment with either C. spinosa
extract (30–300 μg/ml; in a concentration-dependent manner) or dex-
amethasone (0.5 μM) could up-regulate the level of Arg1 gene expres-
sion (p < 0.001 for all cases, Fig. 9B), reduced iNOS gene expression
level, (p < 0.001 for all cases, Fig. 9A), and finally attenuate the level
of iNOS/Arg1 ratio (M1/M2; p < 0.001 for all cases, Fig. 9C), com-
pared to the LPS-treated cells. Moreover, the impact of dexamethasone
(0.5 μM) reduced iNOS gene expression greater than those group
treated with C. spinosa extract (30–300 μg/ml) (p < 0.001 for all cases,
Fig. 9A). At 30 and 100 μg/ml concentration of the extract, the levels of
Arg1 gene expression (p < 0.001 for both cases, Fig. 9B) and iNOS/
Arg1 ratio (M1/M2; p < 0.001 for both cases, Fig. 9C) were observed
significantly lower and greater than that group treated with dex-
amethasone (0.5 μM).
3.3.5. The effects of C. spinosa extract and LPS on the levels of NO, urea
and NO/urea (M1/M2) ratio
Following the LPS stimulation, the levels of NO production
(p < 0.001, Fig. 10A) and urea production (p < 0.001, Fig. 10B) were
significantly increased and deceased, respectively, compared to the
control group. LPS stimulation led to a marked increment in the level of
NO/urea ratio compared to the control group (p < 0.001, Fig. 10C). In
comparison to the LPS group, all concentrations of the extract
(30–300 μg/ml; in a concentration-dependent manner) and also dex-
amethasone (0.5 μM) significantly inhibited NO production
(p < 0.001 for all cases, Fig. 10A), and meaningfully increased the
Fig. 7. Effects of C. spinosa extract on pro-inflammatory factors A) TNF-α, B) IL-
6, and C) IL-1β in LPS-stimulated microglial cells. Concentrations of TNF-α, IL-
6, IL-1β were determined using ELISA. Data represented as mean ± SEM;
n = 6 per group. ###p < 0.001, compared with LPS group; ***p < 0.001,
compared with control group; ++ p < 0.01 and +++ p < 0.001, com-
pared with Dexa group. The presented data were analyzed by one-way ANOVA
with the Tukey post hoc test. LPS, lipopolysaccharide; SEM, standard error
mean; TNF-α, Tumor necrosis factor-α, IL-1β, Interleukin 1-β; IL-6, Interleukin-
6; Dexa, dexamethasone (0.5 μM).
Fig. 8. Effects of C. spinose extract on LPS-induced PGE2 production (A) and
COX-2 mRNA expression (B). The levels of PGE2 and COX-2 were evaluated by
ELISA and real time-PCR, respectively. Data represented as mean ± SEM;
n = 6 per group. ##P < 0.01, ###p < 0.001, compared with LPS group;
***p < 0.001, compared with control group; ++ p < 0.01 and +++
p < 0.001, compared with Dexa group. The presented data were analyzed by
one-way ANOVA with the Tukey post hoc test. LPS, lipopolysaccharide; SEM,
standard error mean; COX-2, cyclooxygenase-2, PGE2, Prostaglandin E2, Dexa,
dexamethasone (0.5 μM).
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level of urea (p < 0.05–0.001 for all cases, Fig. 10B) in comparison to
the LPS group. Eventually, in both the extract (30–300 μg/ml; in a
concentration-dependent manner) and dexamethasone (0.5 μM) treated
groups, the levels of NO/urea ratio were notably decreased in com-
parison to the LPS group (p < 0.001 for all cases, Fig. 10C). We ob-
served that the effects of dexamethasone (0.5 μM) on the reduction of
NO production (p < 0.001 for both cases, Fig. 10A) and also NO/urea
ratio (p < 0.001 for both cases, Fig. 10C), and on the increment of
urea production (p < 0.001 for both cases, Fig. 10B) were more
powerful than those LPS group treated with C. spinosa extract (30 and
100 μg/ml).
4. Discussion
To the best of our knowledge, this is the first study reporting the
protective effects of C. spinosa extract on the reduction of LPS-induced
systemic inflammation associated with cognitive impairment and
neuro-inflammation. In the present study, we assessed the protective
Fig. 9. Effects of C. spinosa extract on the mRNA expression levels iNOS (A) and
Arg1 (B), and iNOS/Arg1 ratio (C) in LPS-stimulated microglial cells. The ex-
pression levels of iNOS and Arg1 were evaluated by real time-PCR. Data re-
presented as mean ± SEM; n = 6 per group. ###p < 0.001, compared with
LPS group; ***p < 0.001, compared with control group; +++ p < 0.001,
compared with Dexa group. The presented data were analyzed by one-way
ANOVA with the Tukey post hoc test. LPS, lipopolysaccharide; SEM, standard
error mean; Arg1, arginase-1; iNOS, inducible nitric oxide synthase.
Fig. 10. Effects of C. spinosa extract on LPS-induced NO (A), urea (B) produc-
tion, and NO/urea (M1/M2) ratio (C). Concentrations of NO and Urea were
determined using ELISA. Data represented as mean ± SEM; n = 6 per group.
###p < 0.001, compared with LPS group; ***p < 0.001, compared with
control group; +++ p < 0.001, compared with Dexa group. The presented
data were analyzed by one-way ANOVA with the Tukey post hoc test. LPS, li-
popolysaccharide; SEM, standard error mean; NO, nitric oxide metabolites;
Dexa, dexamethasone (0.5 μM).
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effects of C. spinosa against LPS-induced inflammation both in-vivo and
in-vitro models. Briefly, our results showed that C. spinosa significantly
and dose-dependently reduced the level of inflammation, and the spa-
tial memory dysfunction following the LPS-induced systemic in-
flammation.
Several studies indicated that inflammation plays an essential role
in memory dysfunction. Contextually, it has been reported that sys-
temic inflammation due to LPS, leads to increasing the activities of
microglia and astrocytes in the brain, which they subsequently result in
spatial memory impairments (Labouesse et al., 2015; Valero et al.,
2014). Neuro-inflammation following the chronic activation of micro-
glia contributes to neurodegenerative processes. In this regard, several
studies have shown that controlling the pro-inflammatory responses by
microglial cells are proposed as a promising therapeutic strategy for
neurodegenerative disease (Baune, 2015; Wang et al., 2015).
In the current study, we observed that systemic and long-term ad-
ministration of LPS leads to both spatial memory impairments (using
MWM test) and neuro inflammation. In fact, LPS-treated animals sig-
nificantly showed longer time spent and traveled distance to find the
platform than the control group. Moreover, following the platform re-
moved, the time spent in target quadrant was lower in animals received
LPS than the control group. These findings imply that the spatial
memory has been impaired in LPS treated animal, because they cannot
remember the location of platform. Additionally, we found that sys-
temic administration of LPS notably increases the levels of in-
flammatory cytokines including IL-1β and TNF-α, and significantly
decreases the level of anti-inflammatory cytokine IL-10, in comparison
to the control group. Interestingly, in the LPS-treated group, we found
that the levels of iNOS (namely M1 marker) and Arg-1 (namely M2
marker) were significantly increased and decreased, respectively, which
leads to an increase in the level of iNOS/Arg-1 (M1/M2) ratios towards
M1 inflammatory phenotypes, in comparison to the control group. In
agreement with these results, previous studies also showed that sys-
temic administration of LPS impairs spatial memory assessing by MWM
and Y-maze tests (Beheshti et al., 2019; Labouesse et al., 2015; Valero
et al., 2014; Yamada et al., 1999). Furthermore, it has been reported
that the systemic inflammation by LPS leads to the activation of glial
cells and production of high levels of inflammatory markers (IL-1β, IL-6
and, TNF-α) which potentially are associated with neuronal dysfunc-
tion, especially in the hippocampus region, and memory and learning
impairments (Beheshti et al., 2019; Labouesse et al., 2015; Valero et al.,
2014; Yamada et al., 1999).
In the LPS-induced inflammation model, activated microglia up-
regulate the expression of iNOS and resultant NO (Bai et al., 2015). Up-
regulation of iNOS is considered an important oxidative component of
the microglial inflammatory response to toxins and noxious stimuli in
the central nervous system (VL et al., 1994; Wong et al., 1996). Excess
NO production by iNOS causes neuronal injury and death (Aquilano
et al., 2008). LPS-mediated neurotoxicity may be partly attributed to
oxidative stress. By in vitro evaluation, our results showed that primary
microglia, under the LPS challenge, produced NO, TNF-??, IL-1β, and
IL-6 and PGE2 involved in process of inflammation. Indeed, LPS could
polarize microglia into the M1 pro-inflammatory phenotype and also
reduced the expression of M2 anti-inflammatory marker which led to
inflammatory responses. These results were consistent with the pre-
vious findings (Askari et al., 2018b; Yang et al., 2017).
In the present study, the anti-neuroinflammatory and microglia-
modulating effects of C. spinosa were evaluated using both in vivo and in
vitro models of inflammatory responses in rats and microglial cells,
respectively. As results, we found that C. spinosa attenuated LPS-in-
duced spatial memory impairment in MWM test. In this regard, several
studies support our findings related to the neuro-protection of C. spi-
nosa. In amyloid-beta (Aβ) peptide injected rat model of AD, C. spinosa
down-regulated the genes involved in inflammation (Mohebali et al.,
2018). The protective properties of the plant against neuroinflamma-
tion was reported due to its antioxidant effects and the presence of
flavonoids including rutin (Mohebali et al., 2018). In line with our re-
sults, Turgut and coworkers showed that 100 and 200 mg/kg of C.
spinosa improve cognitive impairments by D-galactose (Turgut et al.,
2015). In another study, Goel et al. demonstrated that C. spinosa en-
hanced spatial memory in LPS-induced model of cognitive impairments
(Goel et al., 2016). Although our results in consistent with this study,
but there are major differences between our and their model. In this
regard, Goel and their colleagues performed their study with lower dose
(175 μg/kg) and time of exposure (7 days) to LPS, but in the current
study, we carried out the study with optimal dose of LPS (1 mg/kg,
described elsewhere) and longer duration of exposure (33 days). Ad-
ditionally, in our experiment, we examined the levels of inflammatory
(IL-1β and TNF-α) and anti-inflammatory (IL-10) cytokines as well as
the levels of iNOS, Arg-1 and iNOS/Arg-1 ratio, which have been not
evaluated in Goel study. Intriguingly, in the extract treated group, we
observed that the levels of inflammatory (IL-1β and TNF-α) cytokines,
iNOS and iNOS/Arg-1 ratio were dramatically lower than the LPS-
treated group, while anti-inflammatory cytokine (IL-10) was more than
the LPS-treated group. Moreover, this is the first observation to de-
monstrate that C. spinosa is capable to switch microglia polarization
from a pro-inflammatory M1 state towards anti-inflammatory state M2.
Experimentally, our data showed that C. spinosa concentration-de-
pendently suppressed production of NO, and inflammatory mediators
produced by LPS-stimulated microglial cells. These inhibitory effects
were mediated by decreasing both mRNA expression and protein levels
of M1 phenotype markers and pro-inflammatory cytokines, including
TNF-α, IL-1β, IL-6, iNOS and COX-2. Additionally, in the present study,
we realized that C. spinosa reduces Arg1 expression and increased re-
sultant product, urea. It was associated with the switch of microglia
polarization from pro-inflammatory M1 to anti-inflammatory M2 type
indicated by increased Arg1/iNOS ratio as well as reduced NO/urea
ratio. However, further investigation should be considered to support
our data regarding the polarization of M1/M2 cells by im-
munocytochemistry and flow cytometey techniques. The results were
consistent with previous studies reported the anti-inflammatory prop-
erties of C. spinosa (Arena et al., 2008; Hamuti et al., 2017; Kwak et al.,
2002; Lee et al., 2005). The anti-inflammatory activity of ethanolic
extracts of C. spinosa has been demonstrated in the previous experi-
ments. The extracts up-regulated the expression of a cluster of differ-
entiation (CD) 40, CD 80 and CD 86 and also counteracted the release of
pro-inflammatory cytokines including IL-1β, IL-12 p40, IL-6 and IFN-γ
induced by LPS in dendritic cells (Hamuti et al., 2017). In another
study, Isoginkgetin, and ginkgetin, and other bioflavonoids isolated
from C. spinosa prevented NF-κB activation (Zhou et al., 2011). Anti-
inflammatory effects of ginkgetin have been suggested to be mediated
through suppression of COX-2 expression in LPS- treated macrophages
in vitro and also COX-2 expression and PGE2 production in mouse skin
treated with the 3d treatment of 12-O-tetradecanoyl phorbol-13-acetate
(TPA) (Kwak et al., 2002). In vitro exposure of human peripheral blood
mononuclear cells to C. spinosa methanolic extract inhibited replication
of HSV-2, and production of IFN- γ, TNF- α and IL-12 in peripheral
blood mononuclear cells infected with HSV-2. Its polyphenolic active
components, in particular flavonoids, are also found to possess antiviral
and immunomodulatory properties (Arena et al., 2008).
As our study limitation, Apart from measurement of cytokine ex-
pression level in the whole brain, histological analysis seems necessary
to show the degeneration of neurons and to confirm the establishment
of neuroinflammation and cognitive impairment model, but un-
fortunately we performed the study and measured the cytokine ex-
pression levels in the whole brain and lost the brain for histopatholo-
gical evaluation. Therefore, we can suggest this important issue for
investigations in further studies and researchers.
In conclusion, we showed that treatment with C. spinosa enhances
memory and cognitive behavior and anti-inflammatory cytokine IL-10
following the LPS-induced neuro-inflammation. Additionally, we found
that C. spinosa possibly exerts its effect through modulation of microglia
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polarization by shifting inflammatory phenotype (M1) towards anti-
inflammatory phenotype (M2) cells. Our finding provides evidence that
C. spinosa has neuroprotective effect, and might be considered as an
effective therapeutic agent for the treatment of neurodegenerative
diseases that are accompanied by inflammation, such as AD. However,
further investigations seem necessary to clarify the mechanism under-
lying the anti-inflammatory effects of C. spinosa and determine its most
biologically active chemical constituents.
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